Bliss GVS Pharma Stock Scales New 52-Week Peak at Rs 745: Key Reasons Behind the Surge
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Bliss GVS Pharma Share Price moved to Rs 742 on 28 September 2026, up Rs 32.70 or 4.61% from the previous close of Rs 709.30, after touching a fresh 52-week high of Rs 744.75. The company’s market capitalisation stood at Rs 7,542.02 Cr, placing the move in the context of a sizeable listed healthcare name. For readers tracking Bliss GVS Pharma Share Price Today on Univest, the key facts are straightforward: the stock printed a new yearly high, finished close to that level, and did so without any company-specific catalyst being established in the supplied data.
The latest snapshot also shows the day opened at Rs 705 and stayed within a relatively tight intraday range versus the fresh high. Turnover stood at Rs 12.9 Cr. The move is therefore important for Bliss GVS Pharma Share News because it confirms the price event itself, while the supplied information does not identify a separate trigger. In this Bliss GVS Pharma Stock News update, the focus is on what is verified: a fresh 52-week high, a higher closing price than the previous session, and a valuation profile that deserves a closer fundamental reading on Univest.
Bliss GVS Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 742 |
| Previous Close | Rs 709.3 |
| Today's Move | +Rs 32.7 (+4.61%) |
| Open | Rs 705 |
| High | Rs 744.75 |
| Low | Rs 705 |
| Turnover | Rs 12.9 crore |
| Market Capitalisation | Rs 7,542.02 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 742 versus the previous close of Rs 709.3, a rise of 4.61%. The stock opened at Rs 705, reached a high of Rs 744.75 and touched a low of Rs 705.
Bliss GVS Pharma Share Price Today reflected a clear upward session, with the stock opening at Rs 705, matching the day low, and reaching Rs 744.75, which was also the fresh 52-week high. The latest price was Rs 742, leaving the stock Rs 32.70 above the previous close of Rs 709.30. That is a day gain of 4.61%, which makes the session relevant for anyone following Bliss GVS Pharma Share Price Live or checking Bliss GVS Pharma Share Price Update on market news feeds.
The day’s range stayed between Rs 705 and Rs 744.75, so the stock ended near the upper end of the session. Turnover of Rs 12.9 Cr gives a factual measure of traded value for the day, but it should be read only as a transaction value and not as a proxy for any hidden market behaviour. For Bharat investors searching Bliss GVS Pharma Share Price Today or Bliss GVS Pharma Latest News, the core event is simple: the stock set a fresh one-year high and closed just below that level.
Because the fresh 52-week high is a price event rather than a company announcement, the next useful step is to examine valuation and business performance together with the sector context. That is the right bridge from price action into the broader Bliss GVS Pharma Share Price story on Univest.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,542.02 crore |
| P/E Ratio | 55.38x |
| P/B Ratio | 6.12x |
| ROE | 12.11% |
| ROCE | 17.4% |
| EPS | Rs 12.81 |
| Book Value Per Share | Rs 115.94 |
| Dividend Yield | 0.21% |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P/E 55.38x, P/B 6.12x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.
Bliss GVS Pharma Ltd. has a market capitalisation of Rs 7542.02 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.38x, P/B at 6.12x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 115.94, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.67x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.38x |
| Benchmark Median P/E | 32.67x |
| Benchmark Average P/E | 49.59x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 6.12x |
| Benchmark Median P/B | 2.84x |
| Company ROE | 12.11% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 17.4% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 7,542.02 crore |
| Benchmark Median Market Cap | Rs 722.23 crore |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 55.38x, which is above the benchmark median of 32.67x, a difference of +69.51%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.43%, a difference of +5.95%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.1%, a difference of +32.82%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Innova Captab Ltd. | INNOVACAP | 7,335.66 | 46.94 | 6.46 | 13.75 | 15.04 |
| Sanofi India Ltd. | SANOFI | 7,231.39 | 22.33 | 8.75 | 44.5 | 55.46 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,926.35 | 39.96 | 6.49 | 19.06 | 25.3 |
| Aarti Pharmalabs Ltd. | AARTIPHARM | 8,514.38 | 39.95 | 3.89 | 8.5 | 10.77 |
| Morepen Laboratories Ltd. | MOREPENLAB | 6,600.1 | 46.97 | 5.07 | 7.96 | 10.19 |
Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P/E ratio of 55.38x compared with the displayed peer median of 39.96x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 7,542.02 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Bliss GVS Pharma
- The stock touched a fresh 52-week high of Rs 744.75 and last traded at Rs 742.
- The day’s gain was Rs 32.70, or 4.61%, versus the previous close of Rs 709.30.
- Market capitalisation stood at Rs 7,542.02 Cr in the latest snapshot.
- The company reported P/E of 55.38, P/B of 6.12, ROE of 12.11% and ROCE of 17.4%.
- Revenue and net profit for Jun 2026 were Rs 2,855.76 Cr and Rs 500.97 Cr, respectively.
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. That classification is the core business context supplied for the stock, and it is the correct frame for reading its share price, valuation and peer comparisons. For Bliss GVS Pharma Share Price followers on Univest, the relevant company overview here is the industry position and sector classification that the market uses to compare it with other listed pharmaceuticals and drugs names.
The company’s latest financial and market data should therefore be viewed through the same healthcare lens. When readers search Bliss GVS Pharma Share Price or Bliss GVS Pharma Share Price Today, they are usually looking for a factual update, and the supplied dataset provides exactly that: price action, sector membership, valuation, earnings and capital efficiency.
Track Bliss GVS Pharma Share Price on Univest
Use Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Bliss GVS Pharma Share Price on Univest for live price updates, financial ratios, shareholding pattern, sector context, peer comparisons and the latest 52-week levels. Univest presents the stock in a format that helps users review Bliss GVS Pharma Stock News, Bliss GVS Pharma Latest News and Bliss GVS Pharma Stock Analysis in one place.
It also helps users revisit Bliss GVS Pharma Fundamental Analysis alongside company-specific market information without mixing in unsupported claims. For market followers who want a clean factual view of Bliss GVS Pharma Share Price Today, Univest keeps the data and the context together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Bliss GVS Pharma Share Price move today?
Ans. Bliss GVS Pharma Share Price rose 4.61% to Rs 742 and touched Rs 744.75, a fresh 52-week high. The supplied data confirms the price event, but it does not establish a company-specific catalyst.
What is Bliss GVS Pharma Share Price today?
Ans. Bliss GVS Pharma Share Price today stood at Rs 742 in the latest snapshot. The stock opened at Rs 705, touched Rs 744.75 and closed near the day’s upper end.
What is the fresh 52-week high for Bliss GVS Pharma?
Ans. The fresh 52-week high for Bliss GVS Pharma was Rs 744.75. That level also matched the day’s high, while the latest quoted price was slightly below it at Rs 742.
How is Bliss GVS Pharma valued?
Ans. Bliss GVS Pharma has a P/E of 55.38 and a P/B of 6.12. Both are above the same-industry median benchmarks, which places the valuation above the industry median on these measures.
What do Bliss GVS Pharma earnings and book value show?
Ans. EPS is 12.81 and book value is Rs 115.94. These numbers show earnings attributable to each share and the accounting net worth behind each share, helping frame the share price context.
How does Bliss GVS Pharma compare with its industry peers?
Ans. Bliss GVS Pharma’s P/E of 55.38 is above several supplied peers and below Symbiotec Pharmalab. Its ROCE of 17.4% is above Innova Captab, Aarti Pharmalabs and Morepen Laboratories in the peer set.
